Profil
Li Ming Shao currently holds the position of Independent Non-Executive Director at IMPACT Therapeutics, Inc. starting in 2025.
Dr. Shao also serves as Independent Non-Executive Director at Lynk Pharmaceuticals Co. Ltd. beginning in 2025.
The education history includes an undergraduate degree from Fudan University conferred in 1982, a graduate degree from the University of Tokyo conferred in 1990, and a doctorate from the University of Tokyo conferred in 1993.
Postes actifs de Li Ming Shao
| Sociétés | Poste | Début |
|---|---|---|
| IMPACT THERAPEUTICS, INC | Directeur/Membre du Conseil | 23/09/2025 |
Lingke Pharmaceutical (Hangzhou) Co., Ltd. (China)
Lingke Pharmaceutical (Hangzhou) Co., Ltd. (China) BiotechnologyHealth Technology Engages in research and development of small-molecule drugs for tumors and autoimmune diseases | Directeur/Membre du Conseil | 21/11/2025 |
Formation de Li Ming Shao
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Tokyo
University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fudan University
Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IMPACT Therapeutics, Inc.
IMPACT Therapeutics, Inc. BiotechnologyHealth Technology Operates as a commercial-stage biotechnology company that develops anti-cancer therapies and pharmaceutical products | Health Technology |
Lingke Pharmaceutical (Hangzhou) Co., Ltd. (China)
Lingke Pharmaceutical (Hangzhou) Co., Ltd. (China) BiotechnologyHealth Technology Engages in research and development of small-molecule drugs for tumors and autoimmune diseases | Health Technology |
















